-
1
-
-
23844555119
-
MicroRNA gene expression deregulation in human breast cancer
-
Iorio M.V., Ferracin M., Liu C.G., Verones A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
-
(2005)
Cancer Res.
, vol.65
, pp. 7065-7070
-
-
Iorio, M.V.1
Ferracin, M.2
Liu, C.G.3
Verones, A.4
Spizzo, R.5
Sabbioni, S.6
Magri, E.7
Pedriali, M.8
Fabbri, M.9
Campiglio, M.10
Menard, S.11
Palazzo, J.P.12
Rosenberg, A.13
Musiani, P.14
Volinia, S.15
Nenci, I.16
Calin, G.A.17
Negrini, M.18
Croce, C.M.19
-
2
-
-
0142120587
-
Reduced accumulation of specific microRNAs in colorectal neoplasia
-
Michael M.Z., O'Connor S.M., van Host Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
-
(2003)
Mol. Cancer Res.
, vol.1
, pp. 882-891
-
-
Michael, M.Z.1
O'Connor, S.M.2
van Host Pellekaan, N.G.3
Young, G.P.4
James, R.J.5
-
3
-
-
33749507943
-
A small piece in the cancer puzzle: microRNAs at tumor suppressors and oncogenes
-
Kent O.A., Mendell J.T. A small piece in the cancer puzzle: microRNAs at tumor suppressors and oncogenes. Oncogene 2006, 25:6188-6196.
-
(2006)
Oncogene
, vol.25
, pp. 6188-6196
-
-
Kent, O.A.1
Mendell, J.T.2
-
4
-
-
33644853907
-
The colorectal microRNAome
-
Cummins J.M., Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz L.A., Sjoblom T., Barad O., Bentwich Z., Szafranska A.E., Labourier E., Raymond C.K., Roberts B.S., Juhl H., Kinzler K.W., Vogelstein B., Velculescu V.E. The colorectal microRNAome. Proc. Natl. Acad. Sci. 2006, 103:3687-3692.
-
(2006)
Proc. Natl. Acad. Sci.
, vol.103
, pp. 3687-3692
-
-
Cummins, J.M.1
Cummins, J.M.2
He, Y.3
Leary, R.J.4
Pagliarini, R.5
Diaz, L.A.6
Sjoblom, T.7
Barad, O.8
Bentwich, Z.9
Szafranska, A.E.10
Labourier, E.11
Raymond, C.K.12
Roberts, B.S.13
Juhl, H.14
Kinzler, K.W.15
Vogelstein, B.16
Velculescu, V.E.17
-
5
-
-
33747628074
-
Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
-
Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzo M., Garcia-Foncillas J. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 2006, 19:5-29.
-
(2006)
Mol. Cancer
, vol.19
, pp. 5-29
-
-
Bandres, E.1
Cubedo, E.2
Agirre, X.3
Malumbres, R.4
Zarate, R.5
Ramirez, N.6
Abajo, A.7
Navarro, A.8
Moreno, I.9
Monzo, M.10
Garcia-Foncillas, J.11
-
6
-
-
33747876113
-
MicroRNA-cancer connection: the beginning of a new tale
-
Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006, 66:7390-7394.
-
(2006)
Cancer Res.
, vol.66
, pp. 7390-7394
-
-
Calin, G.A.1
Croce, C.M.2
-
7
-
-
67650365554
-
Restoration of tumor suppressor has-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
-
Cho W.C., Chow A.S., Au J.S. Restoration of tumor suppressor has-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer 2009, 45:2197-2206.
-
(2009)
Eur. J. Cancer
, vol.45
, pp. 2197-2206
-
-
Cho, W.C.1
Chow, A.S.2
Au, J.S.3
-
8
-
-
77649271930
-
MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
-
Chiyomaru T., Enokida H., Tatarano S., Kawahara K., Uchida Y., Mishiyama K., Fujimura L., Kikkawa N., Seki N., Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 2010, 102:883-891.
-
(2010)
Br. J. Cancer
, vol.102
, pp. 883-891
-
-
Chiyomaru, T.1
Enokida, H.2
Tatarano, S.3
Kawahara, K.4
Uchida, Y.5
Mishiyama, K.6
Fujimura, L.7
Kikkawa, N.8
Seki, N.9
Nakagawa, M.10
-
9
-
-
75149124701
-
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting Mucin 1
-
Sachdeva M., Mo Y.-Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting Mucin 1. Cancer Res. 2010, 70:378-387.
-
(2010)
Cancer Res.
, vol.70
, pp. 378-387
-
-
Sachdeva, M.1
Mo, Y.-Y.2
-
10
-
-
67349149082
-
MicroRNA-145 regulates OCT4, SOX2 and KLF4 and represses pluripotency in human embryonic stem cells
-
Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2 and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
-
(2009)
Cell
, vol.137
, pp. 647-658
-
-
Xu, N.1
Papagiannakopoulos, T.2
Pan, G.3
Thomson, J.A.4
Kosik, K.S.5
-
11
-
-
68449097267
-
MiR145 and miR143 regulate smooth muscle cell fate and plasticity
-
Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.-H., Miano J.M., Ivey K.N., Srivastava D. miR145 and miR143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
-
(2009)
Nature
, vol.460
, pp. 705-710
-
-
Cordes, K.R.1
Sheehy, N.T.2
White, M.P.3
Berry, E.C.4
Morton, S.U.5
Muth, A.N.6
Lee, T.-H.7
Miano, J.M.8
Ivey, K.N.9
Srivastava, D.10
-
12
-
-
74249123376
-
Mir-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells
-
Spizzo R., Nicoloso M.S., Lupini L., Lu Y., Fogarty J., Rossi S., Zagati B., Fabbri M., Veronese A., Liu X., Davuluri R., Croce C.M., Mills G., Negrini M., Calin G.A. mir-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells. Cell Death Diff. 2010, 17:246-254.
-
(2010)
Cell Death Diff.
, vol.17
, pp. 246-254
-
-
Spizzo, R.1
Nicoloso, M.S.2
Lupini, L.3
Lu, Y.4
Fogarty, J.5
Rossi, S.6
Zagati, B.7
Fabbri, M.8
Veronese, A.9
Liu, X.10
Davuluri, R.11
Croce, C.M.12
Mills, G.13
Negrini, M.14
Calin, G.A.15
-
13
-
-
77149124265
-
MiR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors
-
Ostenfeld M.S., Bramsen J.B., Lamy P., Villadsen S.B., Fristrup N., Sorensen K.D., Ulhoi B., Borre M., Kjems J., Dyrskyot L., Orntoft T.F. miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 2010, 29:1073-1084.
-
(2010)
Oncogene
, vol.29
, pp. 1073-1084
-
-
Ostenfeld, M.S.1
Bramsen, J.B.2
Lamy, P.3
Villadsen, S.B.4
Fristrup, N.5
Sorensen, K.D.6
Ulhoi, B.7
Borre, M.8
Kjems, J.9
Dyrskyot, L.10
Orntoft, T.F.11
-
14
-
-
36348994146
-
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
-
Shi B., Sepp-Lorenzino M., Prisco M., Linsley P., de Angelis T., Baserga R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J. Biol. Chem. 2007, 282:32582-32590.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 32582-32590
-
-
Shi, B.1
Sepp-Lorenzino, M.2
Prisco, M.3
Linsley, P.4
de Angelis, T.5
Baserga, R.6
-
15
-
-
67649373019
-
Mechanism of growth inhibition by microRNA 145: the role of the IGF-1 receptor signaling pathway
-
La Rocca G., Badin M., Shi B., Xiu S.-Q., De Angelis T., Sepp-Lorenzino L., Baserga R. Mechanism of growth inhibition by microRNA 145: the role of the IGF-1 receptor signaling pathway. J. Cell. Physiol. 2009, 220:485-491.
-
(2009)
J. Cell. Physiol.
, vol.220
, pp. 485-491
-
-
La Rocca, G.1
Badin, M.2
Shi, B.3
Xiu, S.-Q.4
De Angelis, T.5
Sepp-Lorenzino, L.6
Baserga, R.7
-
16
-
-
0034682763
-
Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells
-
Valentinis B., Navarro M., Zanocco-Marani T., Edmonds P., McCormick J., Morrione A., Sacchi A., Romano G., Reiss K., Baserga R. Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells. J. Biol. Chem. 2000, 275:25451-25459.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 25451-25459
-
-
Valentinis, B.1
Navarro, M.2
Zanocco-Marani, T.3
Edmonds, P.4
McCormick, J.5
Morrione, A.6
Sacchi, A.7
Romano, G.8
Reiss, K.9
Baserga, R.10
-
17
-
-
11244280921
-
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependent mechanism
-
Del Rincon S.V., Guo Q., Morelli C., Shiu H.Y., Surmacz E., Miller W.H. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependent mechanism. Oncogene 2004, 23:9269-9279.
-
(2004)
Oncogene
, vol.23
, pp. 9269-9279
-
-
Del Rincon, S.V.1
Guo, Q.2
Morelli, C.3
Shiu, H.Y.4
Surmacz, E.5
Miller, W.H.6
-
18
-
-
35148884258
-
Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid
-
Ravikumar S., Perez-Liz G., Del Valle L., Soprano D.R., Soprano K.J. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. Cancer Res. 2007, 67:9266-9275.
-
(2007)
Cancer Res.
, vol.67
, pp. 9266-9275
-
-
Ravikumar, S.1
Perez-Liz, G.2
Del Valle, L.3
Soprano, D.R.4
Soprano, K.J.5
-
19
-
-
34347401998
-
The ubiquitin-specific protease USP28 is required for MYC stability
-
Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R., Bernards R., Moll R., Elledge S.J., Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 2007, 9:765-774.
-
(2007)
Nat. Cell Biol.
, vol.9
, pp. 765-774
-
-
Popov, N.1
Wanzel, M.2
Madiredjo, M.3
Zhang, D.4
Beijersbergen, R.5
Bernards, R.6
Moll, R.7
Elledge, S.J.8
Eilers, M.9
-
20
-
-
0031079684
-
The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number
-
Rubini M., Hongo A., D'Ambrosio C., Baserga R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res. 1997, 230(2):284-292.
-
(1997)
Exp. Cell Res.
, vol.230
, Issue.2
, pp. 284-292
-
-
Rubini, M.1
Hongo, A.2
D'Ambrosio, C.3
Baserga, R.4
-
21
-
-
33745161658
-
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha
-
Ferrari-Amorotti G., Keeshan K., Zattoni M., Guerzoni C., Iotti G., Cattelani S., Donato N.J., Calabretta B. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. Blood 2006, 108(4):1353-1362.
-
(2006)
Blood
, vol.108
, Issue.4
, pp. 1353-1362
-
-
Ferrari-Amorotti, G.1
Keeshan, K.2
Zattoni, M.3
Guerzoni, C.4
Iotti, G.5
Cattelani, S.6
Donato, N.J.7
Calabretta, B.8
-
22
-
-
0041737609
-
Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation
-
Keeshan K., Santilli G., Corradini F., Perrotti D., Calabretta B. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood 2003, 102(4):1267-1275.
-
(2003)
Blood
, vol.102
, Issue.4
, pp. 1267-1275
-
-
Keeshan, K.1
Santilli, G.2
Corradini, F.3
Perrotti, D.4
Calabretta, B.5
-
23
-
-
0033561797
-
Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
-
Melnick A., Licht J.D. Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999, 93:3167-3215.
-
(1999)
Blood
, vol.93
, pp. 3167-3215
-
-
Melnick, A.1
Licht, J.D.2
-
24
-
-
0038457742
-
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI3- kinase/AKT pathway
-
Del Rincon S.V., Rousseau C., Samanta R., Miller W.H. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI3- kinase/AKT pathway. Oncogene 2003, 22:3353-3360.
-
(2003)
Oncogene
, vol.22
, pp. 3353-3360
-
-
Del Rincon, S.V.1
Rousseau, C.2
Samanta, R.3
Miller, W.H.4
-
25
-
-
68049109358
-
Growth inhibition by microRNAs that target the insulin receptor substrate-1
-
La Rocca G., Shi B., Badin M., De Angelis T., Sepp-Lorenzino L., Baserga R. Growth inhibition by microRNAs that target the insulin receptor substrate-1. Cell Cycle 2009, 8(14):2255-2259.
-
(2009)
Cell Cycle
, vol.8
, Issue.14
, pp. 2255-2259
-
-
La Rocca, G.1
Shi, B.2
Badin, M.3
De Angelis, T.4
Sepp-Lorenzino, L.5
Baserga, R.6
-
26
-
-
0035893763
-
Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (paclitaxel)
-
Vivat-Hannah V., You D., Rizzo C., Daris J.P., Lapointe P., Zusi F.C., Marinier A., Lorenzi M.V., Gottardis M.M. Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (paclitaxel). Cancer Res. 2001, 61(24):8703-8711.
-
(2001)
Cancer Res.
, vol.61
, Issue.24
, pp. 8703-8711
-
-
Vivat-Hannah, V.1
You, D.2
Rizzo, C.3
Daris, J.P.4
Lapointe, P.5
Zusi, F.C.6
Marinier, A.7
Lorenzi, M.V.8
Gottardis, M.M.9
-
27
-
-
4744375264
-
GSK3-β inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/Apo1) expression
-
Beurel E., Beurel E., Kornprobst M., Blivet-van Eggelpoel M.J., Ruiz-Ruiz C., Cadoret A., Capeau J., Desbois-Mouthon C. GSK3-β inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/Apo1) expression. Exp. Cell Res. 2004, 300:354-364.
-
(2004)
Exp. Cell Res.
, vol.300
, pp. 354-364
-
-
Beurel, E.1
Beurel, E.2
Kornprobst, M.3
Blivet-van Eggelpoel, M.J.4
Ruiz-Ruiz, C.5
Cadoret, A.6
Capeau, J.7
Desbois-Mouthon, C.8
-
28
-
-
33947582230
-
Downregulation of the upstream binding factor 1 by glycogen synthase 3β in myeloid cells induced to differentiate
-
Liu M., Tu X., Ferrari-Amorotti G., Calabretta B., Baserga R. Downregulation of the upstream binding factor 1 by glycogen synthase 3β in myeloid cells induced to differentiate. J. Cell. Biochem. 2007, 100:1154-1169.
-
(2007)
J. Cell. Biochem.
, vol.100
, pp. 1154-1169
-
-
Liu, M.1
Tu, X.2
Ferrari-Amorotti, G.3
Calabretta, B.4
Baserga, R.5
-
29
-
-
38149008306
-
Kinetic analysis of butyrate transport in human colon adenocarcinoma cells reveals two different carrier-mediated mechanisms
-
Lecona E., Olmo N., Turnay J., Santiago-Gómez A., López de Silanes I., Gorospe M., Lizarbe M.A. Kinetic analysis of butyrate transport in human colon adenocarcinoma cells reveals two different carrier-mediated mechanisms. Biochem. J. 2008, 409:311-320.
-
(2008)
Biochem. J.
, vol.409
, pp. 311-320
-
-
Lecona, E.1
Olmo, N.2
Turnay, J.3
Santiago-Gómez, A.4
López de Silanes, I.5
Gorospe, M.6
Lizarbe, M.A.7
-
30
-
-
67649448828
-
MiR-145 inhibits breast cancer cell growth through RTKN
-
Wang S., Bian C., Yang Z., Bo Y., Li J., Zeng L., Zhou H., Zhao R.C. miR-145 inhibits breast cancer cell growth through RTKN. Int. J. Oncol. 2009, 34:1461-1466.
-
(2009)
Int. J. Oncol.
, vol.34
, pp. 1461-1466
-
-
Wang, S.1
Bian, C.2
Yang, Z.3
Bo, Y.4
Li, J.5
Zeng, L.6
Zhou, H.7
Zhao, R.C.8
-
31
-
-
0037113910
-
Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis
-
Tu X., Batta P., Innocent N., Prisco M., Casaburi I., Belletti B., Baserga R. Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis. J. Biol. Chem. 2002, 277:44357-44365.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 44357-44365
-
-
Tu, X.1
Batta, P.2
Innocent, N.3
Prisco, M.4
Casaburi, I.5
Belletti, B.6
Baserga, R.7
-
32
-
-
0037199956
-
Nuclear translocation of insulin receptor substrate-1 by the simian virus 40T antigen and the activated type 1 insulin-like growth factor receptor
-
Prisco M., Santini F., Baffa R., Liu M., Drakas R., Wu A., Baserga R. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40T antigen and the activated type 1 insulin-like growth factor receptor. J. Biol. Chem. 2002, 277:32078-32085.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 32078-32085
-
-
Prisco, M.1
Santini, F.2
Baffa, R.3
Liu, M.4
Drakas, R.5
Wu, A.6
Baserga, R.7
-
33
-
-
0032005207
-
Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program
-
Valtieri M., Tocci A., Gabbianelli M., Luchetti L., Masella B., Vitelli L., Botta R., Testa U., Condorelli G.L., Peschle C. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res. 1998, 58(3):562-569.
-
(1998)
Cancer Res.
, vol.58
, Issue.3
, pp. 562-569
-
-
Valtieri, M.1
Tocci, A.2
Gabbianelli, M.3
Luchetti, L.4
Masella, B.5
Vitelli, L.6
Botta, R.7
Testa, U.8
Condorelli, G.L.9
Peschle, C.10
-
34
-
-
0033591347
-
Multiple signals mediate proliferation, differentiation and survival from the granulocyte colony stimulating factor receptor in myeloid 32D cells
-
Ward A.C., Smith L., de Koning J.P., van Aesch Y., Touw I.P. Multiple signals mediate proliferation, differentiation and survival from the granulocyte colony stimulating factor receptor in myeloid 32D cells. J. Biol. Chem. 1999, 274:14956-14962.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 14956-14962
-
-
Ward, A.C.1
Smith, L.2
de Koning, J.P.3
van Aesch, Y.4
Touw, I.P.5
-
35
-
-
33646375432
-
Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells
-
Shi B., Prisco M., Calin G., Liu C.-g., Russo G., Giordano A., Baserga R. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J. Cell. Physiol. 2006, 207:706-710.
-
(2006)
J. Cell. Physiol.
, vol.207
, pp. 706-710
-
-
Shi, B.1
Prisco, M.2
Calin, G.3
Liu, C.-G.4
Russo, G.5
Giordano, A.6
Baserga, R.7
-
36
-
-
23844436626
-
Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin
-
Chen J., Wu A., Sun H., Drakas R., Garofalo C., Cascio S., Surmacz E., Baserga R. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J. Biol. Chem. 2005, 280:29912-29920.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 29912-29920
-
-
Chen, J.1
Wu, A.2
Sun, H.3
Drakas, R.4
Garofalo, C.5
Cascio, S.6
Surmacz, E.7
Baserga, R.8
-
37
-
-
38049100505
-
Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes
-
Wu A., Chen J., Baserga R. Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes. Oncogene 2008, 22:397-403.
-
(2008)
Oncogene
, vol.22
, pp. 397-403
-
-
Wu, A.1
Chen, J.2
Baserga, R.3
-
38
-
-
34848868143
-
Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal
-
Rubin R., Arzumanyan A., Soliera A.R., Ross B., Peruzzi F., Prisco M. Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal. J. Cell. Physiol. 2007, 213:445-453.
-
(2007)
J. Cell. Physiol.
, vol.213
, pp. 445-453
-
-
Rubin, R.1
Arzumanyan, A.2
Soliera, A.R.3
Ross, B.4
Peruzzi, F.5
Prisco, M.6
-
39
-
-
0027751663
-
The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
-
Lee R.C., Feinbaum R.L., Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
-
(1993)
Cell
, vol.75
, pp. 843-854
-
-
Lee, R.C.1
Feinbaum, R.L.2
Ambros, V.3
-
40
-
-
28344438648
-
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
-
Fazi F., Rosa A., Fatica A., Gelmetti V., DeMarchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 2005, 123:819-831.
-
(2005)
Cell
, vol.123
, pp. 819-831
-
-
Fazi, F.1
Rosa, A.2
Fatica, A.3
Gelmetti, V.4
DeMarchis, M.L.5
Nervi, C.6
Bozzoni, I.7
-
41
-
-
78650651001
-
Expression of micro RNA -145 is regulated by a highly-conserved genomic sequence 3' to the pre-miR
-
La Rocca G., Bin S., Sepp-Lorenzino L., Baserga R., DeMarchis M.L., Nervi C. Expression of micro RNA -145 is regulated by a highly-conserved genomic sequence 3' to the pre-miR. J. Cell. Physiol. 2010, 226:602-607.
-
(2010)
J. Cell. Physiol.
, vol.226
, pp. 602-607
-
-
La Rocca, G.1
Bin, S.2
Sepp-Lorenzino, L.3
Baserga, R.4
DeMarchis, M.L.5
Nervi, C.6
|